$RVNC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Revance Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Revance Therapeutics, Inc.. Get notifications about new insider transactions in Revance Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2014 | RVNC | Revance Therapeuti ... | Eastman Ronald W | Director | Buy | C | 0.00 | 2,781,396 | 0 | 2,781,396 | 0 to 2.8 M |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | A | 9.15 | 99,583 | 911,184 | 99,583 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | C | 0.00 | 409 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | C | 0.00 | 17,293 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | C | 0.00 | 17,702 | 0 | 71,035 | 53.3 K to 71 K (+33.19 %) |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | WOOTEN RONALD J | Director | Option Exercise | X | 0.00 | 398,717 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | WOOTEN RONALD J | Director | Option Exercise | C | 0.00 | 658,551 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | WOOTEN RONALD J | Director | Option Exercise | C | 0.00 | 500,039 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | WOOTEN RONALD J | Director | Option Exercise | C | 0.00 | 1,539,343 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | WOOTEN RONALD J | Director | Buy | X | 0.00 | 398,717 | 0 | 3,096,650 | 2.7 M to 3.1 M (+14.78 %) |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | WOOTEN RONALD J | Director | Buy | C | 0.00 | 658,551 | 0 | 2,697,933 | 2 M to 2.7 M (+32.29 %) |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | WOOTEN RONALD J | Director | Buy | C | 0.00 | 2,039,382 | 0 | 2,039,382 | 0 to 2 M |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | Tunnicliffe Jonathan | Director | Option Exercise | X | 0.00 | 398,717 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | Tunnicliffe Jonathan | Director | Option Exercise | C | 0.00 | 658,551 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | Tunnicliffe Jonathan | Director | Option Exercise | C | 0.00 | 500,039 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | Tunnicliffe Jonathan | Director | Option Exercise | C | 0.00 | 1,539,343 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | Tunnicliffe Jonathan | Director | Buy | X | 0.00 | 398,717 | 0 | 3,096,650 | 2.7 M to 3.1 M (+14.78 %) |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | Tunnicliffe Jonathan | Director | Buy | C | 0.00 | 658,551 | 0 | 2,697,933 | 2 M to 2.7 M (+32.29 %) |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | Tunnicliffe Jonathan | Director | Buy | C | 0.00 | 2,039,382 | 0 | 2,039,382 | 0 to 2 M |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | NovaQuest Pharma Opportunities ... | 10% Owner | Option Exercise | X | 0.00 | 398,717 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | NovaQuest Pharma Opportunities ... | 10% Owner | Option Exercise | C | 0.00 | 658,551 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | NovaQuest Pharma Opportunities ... | 10% Owner | Option Exercise | C | 0.00 | 500,039 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | NovaQuest Pharma Opportunities ... | 10% Owner | Option Exercise | C | 0.00 | 1,539,343 | 0 | 0 | |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | NovaQuest Pharma Opportunities ... | 10% Owner | Buy | X | 0.00 | 398,717 | 0 | 3,096,650 | 2.7 M to 3.1 M (+14.78 %) |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | NovaQuest Pharma Opportunities ... | 10% Owner | Buy | C | 0.00 | 658,551 | 0 | 2,697,933 | 2 M to 2.7 M (+32.29 %) |
| Feb 11 2014 | RVNC | Revance Therapeuti ... | NovaQuest Pharma Opportunities ... | 10% Owner | Buy | C | 0.00 | 2,039,382 | 0 | 2,039,382 | 0 to 2 M |